Estrella Resources (ASX:ESR) Announces Significant Manganese Discovery
Estrella Resources (ASX:ESR) intersects 6.45m of massive manganese oxides in maiden drill hole at Ira Miri Prospect, marking Timor-Leste’s first modern mineral exploration.
Category: Companies
Everest Metals Corporation Ltd (ASX:EMC) Advances Australian-First Rubidium Industry at Mt Edon
Everest Metals (ASX:EMC) achieves 97% rubidium recovery at Mt Edon, advancing Australia’s inaugural rubidium industry.
Ioneer Ltd (ASX:INR) Quadruples Ore Reserve and Strengthens Rhyolite Ridge Project
Ioneer Ltd (ASX:INR) announces a quadrupling of ore reserves and updated economics for its Rhyolite Ridge Project, enhancing mine life and financial resilience.
James Hardie (ASX:JHX) Syndicates $3.5B in New Credit Facilities
James Hardie (ASX:JHX) syndicates $3.5 billion in new credit facilities to support its operations and planned merger with AZEK.
Axel REE Limited (ASX:AXL) Announces Strategic Leadership Transition
Axel REE (ASX:AXL) announces leadership changes and a strategic restructure to advance its rare earth and gallium projects in Brazil.
Lunnon Metals (ASX:LM8) Reveals New Gold Structures in Sterilisation Drilling
Lunnon Metals (ASX:LM8) discovers new gold structures near Lady Herial, advancing its Kambalda Gold & Nickel Project.
Merchant House International Limited (ASX:MHI) Announces Preliminary Financial Results for FY2025
Merchant House International (ASX:MHI) reports a reduced net loss for FY2025 and outlines plans to wind up the group following strategic asset sales.
New Zealand King Salmon Investments Limited (ASX:NZK) Reduces FY26 Harvest Volumes
New Zealand King Salmon Investments Limited (ASX:NZK) reduces FY26 harvest volumes, revising EBITDA guidance down significantly.
Invion Limited (ASX:IVX) Reports Positive Phase I/II Skin Cancer Trial Results
Invion Limited (ASX:IVX) reports positive safety and efficacy results in Phase I/II skin cancer trial, progressing to next study phase.
Noxopharm Limited (ASX:NOX) Receives Approval for HERACLES Clinical Trial
Noxopharm Limited (ASX:NOX) receives ethics approval for its innovative HERACLES clinical trial, advancing new treatments for chronic inflammatory diseases.